SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status

European Journal of Cancer

Volumn 50, Issue 17, 2014, Pages 2939-2949

  Maguire, J ^a   Khan, I ^b   McMenemin, R ^c   O'Rourke, N ^d   McNee, S ^d   Kelly, V ^a   Peedell, C ^e   Snee, M ^f  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

^d BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^e JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^f St James's Institute of Oncology   (United Kingdom)

Author keywords

Accelerated; Concurrent; Hypofractionation; Keywords NSCLC; Radiotherapy; SOCCAR; Stage III

Indexed keywords

CISPLATIN; NAVELBINE; ANTINEOPLASTIC AGENT; VINBLASTINE;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; ESOPHAGITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADICAL HYPOFRACTIONATED RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; ANALOGS AND DERIVATIVES; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; LUNG NEOPLASMS; MEDICATION COMPLIANCE; MIDDLE AGED; PATHOLOGY; PROCEDURES; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CISPLATIN; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; TREATMENT OUTCOME; VINBLASTINE;

EID: 84922480994     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.07.009     Document Type: Conference Paper

References (19)

1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, and H. Comber Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 6 2013 1374 1403
2. A. Aupérin, C. Le Péchoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 13 2010 2181 2190
3. N. O'Rourke, I. Roqué, and M. Figuls Concurrent chemoradiotherapy in non-small cell lung cancer Cochrane Database Syst Rev 16 6 2010
4. N. Hanna, M. Neubauer, C. Yiannoutsos Hoosier Oncology Group; US Oncology Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and US Oncology J Clin Oncol 26 35 2008 5755 5760
5. K. Kelly, K. Chansky, and L.E. Gaspar Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023 J Clin Oncol 26 15 2008 2450 2456 10.1200/JCO.2007.14.4824
6. K.S. Albain, R.S. Swann, and V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 9687 2009 379 386
7. J.D. Bradley, R. Paulus, and R. Komaki A randomised phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617 J Clin Oncol 31 2013 suppl; abstr 7501
8. ICRU (The International Commission on Radiation Units and Measurements) Report 50: Prescribing, recording and reporting Photon Beam Therapy. Landberg T, Chavandra J and Dobbs et al. 1993 ICRU Publications Bethesda.
9. T.J. Perren, A.M. Swart, J. Pfisterer, J.A. Ledermann, E. Pujade-Lauraine, and G. Kristensen ICON7 Investigators. A phase 3 trial of bevacizumab in ovarian cancer N Engl J Med 365 26 2011 2484 2496
10. SAS Institute Inc Cary, NC.
11. O.S. Din, S.V. Harden, and E. Hudson Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres Radiother Oncol 109 1 2013 8 12
12. J. Belderbos, L. Uitterhoeve, N. van Zandwijk EORTC LCG and RT Group Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) Eur J Cancer 43 1 2007 114 121
13. M. Saunders, S. Dische, and A. Barrett Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART steering committee Radiother Oncol 52 2 1999 137 148
14. M. Baumann, T. Herrmann, R. Koch CHARTWEL-Bronchus study group Final results of the randomised phase IIICHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 1 2011 76 85
15. C.P. Belani, W. Wang, D.H. Johnson Eastern Cooperative Oncology Group Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer J Clin Oncol 23 16 2005 3760 3767
16. M. Hatton, M. Nankivell, and E. Lyn Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomised trial Int J Radiat Oncol Biol Phys 81 3 2011 712 718
17. A. Maguen, C. Le Pechoux, and M. Saunders Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis J Clin Oncol 22 2012 2788 2797
18. A. Mauguen, J.P. Pignon, S. Burdett on behalf of the Surrogate Lung Project Collaborative Group Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data Lancet Oncol 14 7 2013 619 626
19. J.D. Cox Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys 82 3 2012 1042 1044